Santa Fe Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-103,678
Closed -$1.91M 50
2015
Q4
$1.91M Sell
103,678
-24,517
-19% -$439K 0.31% 138
2015
Q3
$2.1M Buy
128,195
+19,746
+18% +$338K 0.28% 145
2015
Q2
$1.92M Sell
108,449
-13,435
-11% -$240K 0.26% 151
2015
Q1
$2.16M Sell
121,884
-129,016
-51% -$2.04M 0.26% 152
2014
Q4
$3.32M Buy
250,900
+167,027
+199% +$2.14M 0.42% 73
2014
Q3
$991K Sell
83,873
-3,527
-4% -$44.4K 0.15% 262
2014
Q2
$1.12M Sell
87,400
-30,523
-26% -$397K 0.17% 250
2014
Q1
$1.59M Buy
+117,923
New +$1.55M 0.23% 182
2013
Q4
Sell
-162,307
Closed -$1.91M 474
2013
Q3
$1.91M Buy
162,307
+118,968
+275% +$1.29M 0.36% 110
2013
Q2
$401K Buy
+43,339
New +$368K 0.08% 372

Other funds holding BSX

Santa Fe Partners's BSX Position: Q1 2016 in Review

Santa Fe Partners sold out of Boston Scientific (BSX) in Q1 2016, closing a stake of 103,678 shares — an estimated $1.91M sold.

Santa Fe Partners first reported a position in BSX in Q2 2013 and held it in 10 quarters. The position peaked at $3.32M in Q4 2014. 491 funds tracked by Wall St. Rank hold BSX as of Q1 2016.

  • Santa Fe Partners reported no remaining Boston Scientific position as of Q1 2016 after selling out during the quarter.
  • Santa Fe Partners sold 103,678 Boston Scientific shares in Q1 2016, an estimated $1.91M.
  • Santa Fe Partners first reported a position in Boston Scientific in Q2 2013 and held it in 10 quarters.
  • Santa Fe Partners's Boston Scientific position peaked at $3.32M in Q4 2014.
  • 491 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2016.

Based on Santa Fe Partners's 13F filing for Q1 2016.